Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metyrapone in Mild Autonomous Cortisol Secretion (MACS)
NCT06106295Phase 2Active, not recruiting
- Sponsor
- Mayo Clinic
- Start
- Dec 2023
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metyrapone in Autonomous Cortisol Secretion (ACS), sponsored by Mayo Clinic. Started Dec 2023; status: active, not recruiting.
02
Drugs
metyrapone
03
Conditions
Autonomous Cortisol Secretion (ACS)
Beyond the preview
Go deeper on NCT06106295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06106295.